ScienceDex / Researcher record
Langenfeld, John
- Rbhs -Cancer Institute of New Jersey (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2018 | $363,713 | 1 | #25,049 |
| 2019 | $716,514 | 2 | #12,877 |
| 2021 | $363,713 | 1 | #29,502 |
| 2022 | $1,012,244 | 4 | #9,620 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20181 record
- FY20192 records
- FY20211 record
- FY2022 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Langenfeld, John as a PI. Multi-PI records show the full award amount for context.
- 3R01CA225830-05S1R01Contact PIDetermining the mechanisms by which bone morphogenetic protein inhibition promotes survival/neurogenesis and to trigger AMPK hyperactivation that includes neuronal and cancer death cell$391.2Kaward amount
- 5R01CA225830-05R01Contact PIDeveloping bone morphogenetic receptor II inhibitors for the treatment of cancer$356.4Kaward amount
- 3R01CA225830-05S2R01Contact PIDeveloping bone morphogenetic receptor II inhibitors for the treatment of cancer$201.5Kaward amount
- 3R01CA225830-04S1R01Contact PITargeting BMP type 2 receptor for the treatment of breast cancer.$63.2Kaward amount
Award organization
Organizations that administered FY2022 awards listing Langenfeld, John as a PI.
FY2022 award administered by Rbhs -Cancer Institute of New Jersey (NJ).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardRbhs -Cancer Institute of New Jersey
- 2019$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019R01 Grant Holder
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #9620